TTM
$2.70B
YoY change
-3.0%
5Y CAGR
+3.2%
Peak year (2016)
$2.76B
Cumulative EBITDA
$42.93B
EBITDA history chart for DaVita (DVA) from 1994 to 2025
Latest: $2.64B
EBITDA growth chart for DaVita (DVA) from 1994 to 2025
Latest: -3.0%
EBITDA history table for DaVita (DVA) from 1994 to 2025
| 2025 | $2.64B | -3.0% | −$82.63M | ||
| 2024 | $2.72B | +17.4% | +$403.63M | ||
| 2023 | $2.32B | +12.9% | +$265.19M | ||
| 2022 | $2.06B | -17.2% | −$428.46M | ||
| 2021 | $2.48B | +10.3% | +$231.56M | ||
| 2020 | $2.25B | -0.1% | −$1.61M | ||
| 2019 | $2.25B | +6.0% | +$127.47M | ||
| 2018 | $2.13B | -18.4% | −$480.96M | ||
| 2017 | $2.61B | -5.4% | −$149.57M | ||
| 2016 | $2.76B | +59.0% | +$1.02B | ||
| 2015 | $1.73B | -24.9% | −$576.11M | ||
| 2014 | $2.31B | +10.9% | +$227.24M | ||
| 2013 | $2.08B | +27.5% | +$449.89M | ||
| 2012 | $1.63B | +14.6% | +$208.76M | ||
| 2011 | $1.43B | +23.1% | +$267.79M | ||
| 2010 | $1.16B | -1.3% | −$15.74M | ||
| 2009 | $1.17B | +6.8% | +$74.54M | ||
| 2008 | $1.10B | +4.0% | +$42.74M | ||
| 2007 | $1.06B | +15.7% | +$142.95M | ||
| 2006 | $912.73M | +56.0% | +$327.64M | ||
| 2005 | $585.09M | +25.1% | +$117.30M | ||
| 2004 | $467.79M | +7.6% | +$33.17M | ||
| 2003 | $434.62M | -3.1% | −$13.87M | ||
| 2002 | $448.49M | +7.8% | +$32.42M | ||
| 2001 | $416.07M | +43.0% | +$125.19M | ||
| 2000 | $290.88M | +54.5% | +$102.57M | ||
| 1999 | $188.30M | -37.9% | −$115.10M | ||
| 1998 | $303.40M | +83.7% | +$138.20M | ||
| 1997 | $165.20M | +56.3% | +$59.50M | ||
| 1996 | $105.70M | +218.4% | +$72.50M | ||
| 1995 | $33.20M | +51.6% | +$11.30M | ||
| 1994 | $21.90M | — | — |
- 2025$2.64B-3.0%
- 2024$2.72B+17.4%
- 2023$2.32B+12.9%
- 2022$2.06B-17.2%
- 2021$2.48B+10.3%
- 2020$2.25B-0.1%
- 2019$2.25B+6.0%
- 2018$2.13B-18.4%
- 2017$2.61B-5.4%
- 2016$2.76B+59.0%
- 2015$1.73B-24.9%
- 2014$2.31B+10.9%
- 2013$2.08B+27.5%
- 2012$1.63B+14.6%
- 2011$1.43B+23.1%
- 2010$1.16B-1.3%
- 2009$1.17B+6.8%
- 2008$1.10B+4.0%
- 2007$1.06B+15.7%
- 2006$912.73M+56.0%
- 2005$585.09M+25.1%
- 2004$467.79M+7.6%
- 2003$434.62M-3.1%
- 2002$448.49M+7.8%
- 2001$416.07M+43.0%
- 2000$290.88M+54.5%
- 1999$188.30M-37.9%
- 1998$303.40M+83.7%
- 1997$165.20M+56.3%
- 1996$105.70M+218.4%
- 1995$33.20M+51.6%
- 1994$21.90M—
EBITDA values are taken from DaVita's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at DaVita (DVA)
According to DaVita's latest reported financial statements, the company's current EBITDA (TTM) is $2.70B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of DaVita (DVA) EBITDA is $2.64B – edged down 3.0% year-over-year.
Over 2020–2025 (5 years), DaVita EBITDA expanded at a +3.2% compound annual rate, with mixed annual results across the window.
DaVita EBITDA peaked at $2.76B in 2016; the latest annual figure is $2.64B in 2025 (4.2% below peak).
Across the available history, EBITDA reached its high of $2.76B in 2016 and its low of $21.90M in 1994.
DaVita EBITDA by Year
DaVita EBITDA 2025: $2.64B
2025's EBITDA for DaVita came in at $2.64B, edged down 3.0% below 2024.
DaVita EBITDA 2024: $2.72B
DaVita posted EBITDA of $2.72B in 2024, grew 17.4% from 2023.
DaVita EBITDA 2023: $2.32B
In 2023, DaVita reported EBITDA of $2.32B, grew 12.9% from 2022.
DaVita EBITDA 2022: $2.06B
DaVita EBITDA in 2022 was $2.06B, declined 17.2% below 2021.
DaVita EBITDA 2021: $2.48B
DaVita EBITDA in 2021 was $2.48B.
See more financial history for DaVita (DVA).
Sector peers by EBITDA
Healthcare peers of DaVita (DVA), ranked by their latest EBITDA
| $41.05B | |
| $28.26B | |
| $27.94B | |
| $24.43B | |
| $23.06B | |
| $19.83B | |
| $17.63B | |
| $16.90B |
- $41.05B
- $28.26B
- $27.94B
- $24.43B
- $23.06B
- $19.83B
- $17.63B
- $16.90B
Frequently asked questions
DaVita (DVA) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation